Skip to main content

Orenitram FDA Approval History

FDA Approved: Yes (First approved December 20, 2013)
Brand name: Orenitram
Generic name: treprostinil
Dosage form: Extended-Release Tablets
Company: United Therapeutics Corporation
Treatment for: Pulmonary Arterial Hypertension

Orenitram (treprostinil extended-release) is an oral prostacyclin for the treatment of pulmonary arterial hypertension.

Development timeline for Orenitram

Dec 30, 2013Approval FDA Approves Orenitram (treprostinil) Extended-Release Tablets for the Treatment of Pulmonary Arterial Hypertension
Sep 12, 2013United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.